| NDC Code: |
51079-104 |
| Proprietary Name: |
Spironolactone and Hydrochlorothiazide |
| Suffix: |
|
| Non-Proprietary Name: |
spironolactone and hydrochlorothiazide |
| Dosage Form: |
TABLET |
| Method: |
ORAL |
| Original Marketing Date: |
23-08-2011 |
| Category Name: |
ANDA |
| Application Number: |
ANDA086513 |
| Labeler: |
UDL LABORATORIES, INC. |
| Substance Name: |
HYDROCHLOROTHIAZIDE; SPIRONOLACTONE |
| Active Numerator Strength: |
25; 25 |
| Active Ingredient Unit: |
mg/1; mg/1 |
| Pharm Classes: |
Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient] |
| DEA Schedule: |
|
